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 2012 EMBO Molecular MedicineAtherosclerotic lesions are asymmetric focal thickenings of the intima of arteries
that consist of lipids, various cell types and extracellular matrix (ECM). These
lesions lead to vascular occlusion representing the most common cause of death
in the Western world. The main cause of vascular occlusion is rupture of
atheromatous lesions followed by thrombus formation. Fibronectin (FN) is one
of the earliest ECM proteins deposited at atherosclerosis-prone sites and was
suggested to promote atherosclerotic lesion formation. Here, we report that
atherosclerosis-prone apolipoprotein E-null mice lacking hepatocyte-derived
plasma FN (pFN) fed with a pro-atherogenic diet display dramatically reduced
FN depositions at atherosclerosis-prone areas, which results in significantly
smaller and fewer atherosclerotic plaques. However, the atherosclerotic lesions
from pFN-deficient mice lacked vascular smooth muscle cells and failed to
develop a fibrous cap. Thus, our results demonstrate that while FN worsens
the course of atherosclerosis by increasing the atherogenic plaque area, it
promotes the formation of the protective fibrous cap, which in humans prevents
plaques rupture and vascular occlusion.INTRODUCTION
Atherosclerosis is a progressive inflammatory disease of large
arteries characterized by an accumulation of lipids and
extracellular matrix (ECM) proteins in the affected vessel wall
(Lusis, 2000). Atherosclerosis commences with the deposition





anyrecruitment of monocytes to the luminal surface of the
endothelium. Next, monocytes transmigrate across the endothe-
lial monolayer into the intima, where they proliferate and
differentiate into macrophages that take up the lipoprotein
particles and form foam cells (Woollard & Geissmann, 2010).
Finally, macrophage-derived chemoattractants induce the
migration of vascular smooth muscle cells (vSMC) from the
vessel wall into the lesion, where they secrete ECM proteins
resulting in lesion growth and the formation of the ‘fibrous cap’
that encloses the lipid-rich core (Newby & Zaltsman, 1999). The
rupture of fibrous caps represents an injured vessel surface
and triggers adhesion and activation of platelets, which can
culminate in thrombus formation and eventually myocardial
infarction or stroke (Lusis, 2000). Therefore, the rupture of an
atherosclerotic plaque always represents a life-threatening
event. Plaque rupture depends on many factors including the
composition and vulnerability of plaques (Lusis, 2000).
Vulnerable plaques have thin fibrous caps and contain elevated
numbers of inflammatory cells (Newby, 2007; Newby et al,
2009).EMBO Mol Med 4, 564–576 www.embomolmed.org
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which comprise hypercholesterolemia, hyperglycemia, obesity
and smoking, atherosclerotic lesions develop preferentially at
vessel curvatures, branching points and bifurcations, where the
blood flow is highly turbulent (Hahn & Schwartz, 2009). In vitro
studies suggested that the turbulent blood flow at these
atherosclerotic-prone sites exerts mechanical forces on endothe-
lial cells (EC) leading to the activation of EC integrins, the
secretion and deposition of fibronectin (FN) (Feaver et al, 2010)
and the activation of inflammatorymediators such as NF-kB, the
c-Jun NH2-terminal kinases (JNKs) and p21-activated kinase
(PAK) (Funk et al, 2010; Hahn & Schwartz, 2008; Hahn et al,
2009; Orr et al, 2005, 2007, 2008). These mediators induce
endothelial permeability, sustain an inflammatory state and
thereby enforce the consequences of the turbulent blood flow
during atherogenesis (Hahn et al, 2009; Orr et al, 2005, 2007).
FNs are a family of large ECM proteins that are generated
by alternative splicing from a single gene. FN is found in all
vertebrates where it exists in two different forms; one form is
cellular FN (cFN), which contains, depending on the tissue,
variable proportions of the alternatively spliced exons coding for
the extra domains A and B (EDA, EDB). cFN is synthesized and
secreted by many cells and assembled into an insoluble fibrillar
matrix. The other form is plasma FN (pFN), which lacks EDA
and EDB. pFN is synthesized by hepatocytes and released into
the circulation where it remains soluble (Leiss et al, 2008; White
et al, 2009). Assembly of FN into insoluble and biologically
active fibrils critically depends on the interaction with integrins
resulting in the unmasking of cryptic FN binding sites,
association with other FN proteins and finally crosslinking by
tissue transglutaminases into a fibrillar matrix (Hynes, 2002;
Leiss et al, 2008). Soluble pFN can also be assembled into fibrils,
however, only after it is bound by integrins, e.g. on platelets or
after transfer into tissues (Moretti et al, 2007; Oh et al, 1981).
Studies published more than 20 years ago showed that the
expression of FN is elevated in vessel walls of atherosclerotic
regions and, therefore, suggested a role for FN during the course
of atherosclerosis (Glukhova et al, 1989). Deletion of the FN
gene in mice leads to early embryonic lethality (George et al,
1993), which precludes the analysis of atherosclerosis. How-
ever, a specific ablation of the exon encoding the alternatively
spliced EDA domain in atherosclerosis-prone mice was reported
to reduce the number and size of atherosclerotic lesions,
suggesting that the EDA domain in cFN supports atherogenesis
(Babaev et al, 2008; Tan et al, 2004). In line with this
observation, the expression of FN-EDA is high during athero-
sclerosis (Astrof & Hynes, 2009). A correlation between elevated
pFN levels and increased incidence for atherosclerosis in human
patients has been shown in some studies but also refuted in
others (Orem et al, 2003; Ozcelik et al, 2009; Tzanatos et al,
2009; Vavalle et al, 2007; Zhang et al, 2006).
To elucidate the functions of pFN and monocyte/
macrophage-derived FN in atherosclerosis, we used the Cre
recombinase-loxP sites (Cre-loxP) system to delete the FN
gene in either hepatocytes and/or haematopoietic cells of
atherosclerosis-prone (ApoE)-null mice. While deleting FN in
haematopoietic cells did not affect plaque formation, loss of pFNwww.embomolmed.org EMBO Mol Med 4, 564–576reduced FN deposits in the subendothelial space of athero-
sclerosis-prone regions and diminished the number and size of
atherosclerotic lesions. Importantly, it also blocked the invasion
of vSMCs and the formation of fibrous caps. Thus, pFN plays a
dichotomous role in atherosclerosis: it promotes disease by
supporting initiation and progression of atherosclerotic lesions
but may prevent potential thrombotic events by promoting
fibrous cap formation.RESULTS
FN is deposited at atherosclerosis-prone sites
There are conflicting observations on a correlation of elevated
pFN levels with an increased incidence for atherosclerosis in
human patients (Orem et al, 2003; Ozcelik et al, 2009; Tzanatos
et al, 2009; Vavalle et al, 2007; Zhang et al, 2006). To determine
whether pFN plays a role during the course of the disease, we
manipulated pFN expression in atherosclerosis-prone ApoE/
mice using the Cre-loxP system. ApoE/ mice subjected to a
high-fat diet develop atherosclerotic lesions over the course of
their lifespan (Nakashima et al, 1994). To first test whether FN
accumulates at sites of disturbed flow in our model system, we
induced atherosclerosis in 3-week-old ApoE/ mice by feeding
them for 12 weeks with a high-fat diet. Oil Red O staining of
aortas and the vessels branching from the aortic arch (the
innominate, the left common carotid and the left subclavian
arteries) confirmed the formation of large, lipid-rich plaques at
areas of disturbed blood flow in the innominate and subclavian
arteries, and the lesser curvature of the aortic arch (Fig 1A). The
Oil Red O-positive plaques were absent before subjecting
ApoE/ mice to the high-fat diet (Fig 1A). Furthermore, cross-
sections revealed FN depositions in atherosclerosis-prone
regions of aortic arches and innominate arteries, while cross-
sections of regions of the aorta and the carotids protected from
atherosclerosis did not show FN accumulations (Fig 1B).
Mx-Cre-mediated FN gene deletion reduced atherosclerotic
plaque formation in vivo
Since FN depositions are particularly prominent in the
subendothelial space and at the luminal surface of athero-
sclerosis-prone regions (Fig 1B), we hypothesized that soluble
pFN is deposited at these sites and thus might play an important
role in atherosclerosis. To test this hypothesis, we intercrossed
ApoE/ mice carrying a loxP-flanked FN gene (ApoE/FNfl/fl)
with mice expressing the Cre recombinase under the control of
the interferon- and polyinosinic-polycytidylic acid (poly-IC)-
inducible Mx promoter (Mx-Cre) to produce ApoE/FNMxCre
mice. Deletion of the FN gene was induced in 2-week-old
ApoE/FNMxCre mice by a single intraperitoneal injection of
poly-IC. Western blot (WB) analysis confirmed loss of pFN
1 week after the poly-IC injection (Fig 2A). Elimination of
pFN was stable for at least 6 months. WB analysis of cell lysates
from ApoE/FNMxCre mice showed loss of FN expression in
haematopoietic cells but neither in ECs nor in vSMCs from the
aorta (Fig 2A and Supporting Information Fig 1A). Together,
these results show thatMx-Cre-mediated deletion of the FN gene 2012 EMBO Molecular Medicine 565
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Figure 1. Fatty streaks and FN depositions at atherosclerosis-prone sites.
A. Whole-mount staining of Oil Red O of an aortic arch from ApoE/ mice
before and after feeding a high fat diet. AA, ascending aorta; BA,
brachiocephalic artery; RSA, right subclavian artery; RCCA, right common
carotid artery; LCCA, left common carotid artery; LSA, left subclavian
artery; DA, descending aorta.
B. Immunostaining of FN of the aortic arch from ApoE/ mice before the
high fat diet. FN stains at the luminal side (arrow heads). Nuclei are
visualized with DAPI. Scale bars represent 75mm.
566was efficient in hepatocytes and haematopoietic cells resulting
in a complete and stable elimination of pFN in ApoE/FNMxCre
mice.
To test whether loss of pFN affects development and/or
progression of atherosclerosis, we subjected ApoE/FNMxCre
and their control (ApoE/FNfl/fl) littermates to high-fat diet and
performed whole-mount staining of longitudinally opened
aortas with Oil Red O to visualize the lipid-rich atherosclerotic
plaques. To avoid possible confounding effects of gender
differences (Goldbourt & Neufeld, 1986), all experiments were
performed with males. After 1 week of high-fat diet, none of the 2012 EMBO Molecular Medicinetest groups displayed signs of atherosclerotic plaque formation.
After 12 weeks of high fat diet, all mice developed athero-
sclerotic lesions with highest incidence at aortic arches and in
the abdominal regions of the aorta (Fig 2B and Supporting
Information Fig 1B). However, ApoE/FNMxCre mice showed
significantly fewer atherosclerotic lesions when compared
to ApoE/FNfl/fl control littermates (Fig 2B–E). Quantitative
analysis of Oil Red O-stained whole mount aortas revealed that
ApoE/FNMxCre aortas displayed a 50% reduction of lesion
areas (Fig 2C), which was due to significantly fewer (Fig 2D)
as well as smaller lesions (Fig 2E). Altogether, these results
indicate that Mx-Cre-mediated deletion of the FN gene protects
against atherosclerosis.
Vav-Cre-mediated FN gene deletion in haematopoietic cells
does not affect atherosclerosis
The Mx-Cre transgene is known to efficiently disrupt floxed
genes in hepatocytes and haematopoietic cells. To determine
whether ablation of the FN gene in haematopoietic cells
including monocytes/macrophages affects the course of athero-
sclerosis, we intercrossed ApoE/FNfl/fl mice with mice
expressing the Cre recombinase under the control of the Vav
promoter (Vav-Cre) to generate ApoE/FNVavCre mice. WB
analysis of cell lysates from ApoE/FNVavCre mice showed loss
of FN expression in haematopoietic cells but neither in
hepatocytes nor in ECs and vSMCs from aorta (Fig 3A and
unpublished observation). Consistent with normal FN gene
activity in hepatocytes, ApoE/FNVavCre mice showed similar
pFN levels as ApoE/FNfl/fl control littermates (Fig 3A and
Supporting Information Fig 1C).
Similar to ApoE/FNfl/fl and ApoE/FNMxCre mice,
ApoE/FNVavCre mice did not develop atherosclerotic lesions
after 1 week of high-fat diet. However, after 12 weeks of a high-
fat diet, ApoE/FNVavCre mice displayed atherosclerotic
plaques at atherosclerosis-prone regions (Fig 3B). The overall
areas covered with lesions as well as the atherosclerotic
plaque sizes and numbers did not differ from those observed in
ApoE/FNfl/fl control littermates (Fig 3C–E). These findings
indicate that FN derived from haematopoietic cells does not
exert a major impact on the development of atherosclerosis.
Loss of pFN reduced FN deposition at atherosclerosis-prone
areas
Lack of pFN significantly reduced the size and number of
atherosclerotic lesions. It has been postulated and confirmed in
this study (Fig 1B) that FN is deposited at atherosclerosis-prone
areas before lesions become visible (Hahn et al, 2009; Orr et al,
2005). To this end, we treated ApoE/FNfl/fl, ApoE/FNVavCre
and ApoE/FNMxCre mice for 1 week with a high-fat diet and
subsequently compared the extent of FN depositions in cross-
sections of the atherosclerosis-prone lesser curvature of aortic
arches.
Neither mouse strain showed evidence of atherosclerotic
plaques after 1 week of high-fat diet. ApoE/FNfl/fl and
ApoE/FNVavCre mice showed continuous FN deposits at
atherosclerosis-prone areas (Fig 4A). In contrast,
ApoE/FNMxCre mice displayed significantly less and oftenEMBO Mol Med 4, 564–576 www.embomolmed.org
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Figure 2. Reduced incidence of atherosclerosis in
ApoE/FNMxCre mice.
A. FN levels in macrophage, EC and vSMC lysates
and plasma from ApoE/FNfl/fl and
ApoE/FNMxCre mice, respectively. Tubulin levels
served as loading control.
B. Whole-mount of longitudinally opened aortas
from ApoE/FNfl/fl and ApoE/FNMxCre mice
stained with Oil Red O after 12 weeks on a high-
fat diet. Scale bar represents 0.5 cm.
C. Quantification of atherosclerotic lesions in aortas
from ApoE/FNfl/fl (n¼26) and ApoE/FNMxCre
(n¼ 18) mice after 12 weeks on a high-fat diet.
Data is presented as a mean of atherosclerotic
plaque area per total aorta area. Values are
mean SD; p¼ 0.000007. n.s.¼ not significant.
D. Quantification of plaque number per aorta. Data
is presented as mean of number of plaques per
aorta from ApoE/FNfl/fl (n¼ 26) and
ApoE/FNMxCre (n¼ 18) mice. Values are
percentage SD; p¼0.03.
E. Quantification of relative size of single lesions.
Values are mean SD; p¼0.024, 0.035, 0.49 and
0.0014. n.s.¼not significant.discontinuous FN staining at the corresponding sites (Fig 4A).
These results indicate that pFN, but not haematopoietic cell-
derived FN, is deposited at atherosclerosis-prone sites prior to
the development of atherosclerotic lesions.
Obesity and hypercholesterolemia are major risk factors for
developing atherosclerosis (Lusis, 2000). Since hepatocytes play
an important role in cholesterol homeostasis and FN is deleted
in these cells, we determined total cholesterol, high-density
lipoprotein (HDL) cholesterol and glucose levels and body
weight in ApoE/FNfl/fl and ApoE/FNMxCre mice treated for
12 weeks with a high-fat diet. We found no differences in either
cholesterol, HDL (Fig 4B) and glucose levels (Fig 4C) or in body
weight (Fig 4D) between ApoE/FNfl/fl and ApoE/FNMxCre
mice. These results exclude an involvement of risk factors in the
differential development of atherosclerosis in ApoE/FNfl/fl
and ApoE/FNMxCre mice.
Expression of inflammatory mediators and recruitment of
monocytes are reduced in ApoE/FNMxCre mice
Integrin-FN interactions are believed to promote monocyte/
macrophage recruitment and to maintain an inflammatorywww.embomolmed.org EMBO Mol Med 4, 564–576milieu at atherosclerosis-prone sites by sustaining shear stress-
induced NF-kB and PAK activation in ECs, which in turn leads to
the expression of downstream genes such as ICAM-1 (Orr et al,
2007) or the activation of signalling molecules such as JNK
(Hahn et al, 2009). To analyze whether pFN modulates NF-kB,
PAK and JNK activity in vivo, we compared the levels of the
phosphorylated NF-kB subunit p65, phospho-PAK, phospho-
JNK and ICAM-1 on cross-sections of the atherosclerosis-prone
lesser curvatures of aortic arches from ApoE/FNfl/fl and
ApoE/FNMxCre mice fed for 1 week with a high-fat diet.
ApoE/FNfl/fl mice had abundant phospho-NF-kB/p65, phos-
pho-PAK throughout ECs, phospho-JNK enriched in nuclei and
ICAM-1 on the luminal surface of the ECs (Fig 5A). In contrast,
ApoE/FNMxCre mice displayed lower levels of phospho-
NF-kBp65, phospho-PAK, phospho-JNK and ICAM-1 in corre-
sponding areas (Fig 5A). Interestingly, atherosclerotic plaques
of ApoE/FNfl/fl and ApoE/FNMxCre mice fed for 10 weeks
with a high-fat diet showed similar expression of all tested
inflammatory markers (Supporting Information Fig 2A). These
results indicate that depositions of pFN facilitate activation of
inflammatory mediators at atherosclerosis-prone sites in vivo. 2012 EMBO Molecular Medicine 567
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Figure 3. Normal incidence of atherosclerosis in
ApoE/FNVavCre mice.
A. FN levels in macrophage, EC and vSMC lysates
and plasma from ApoE/FNfl/fl and
ApoE/FNVavCre mice, respectively. Tubulin
levels served as loading control.
B. Whole-mount of longitudinally opened aortas
from ApoE/FNfl/fl and ApoE/FNVavCre mice
stained with Oil Red O after 12 weeks on a high-
fat diet. Scale bar represents 0.5 cm.
C. Quantification of atherosclerotic lesions in aortas
from ApoE/FNfl/fl (n¼ 9) and ApoE/FNVavCre
(n¼ 9) mice after 12 weeks on a high-fat diet.
Data is presented as a mean of atherosclerotic
plaque area per total aorta area. Values are
mean SD; p¼ 0.96. n.s.¼not significant.
D. Quantification of plaque numbers per aorta. Data
is presented as mean of number of plaques
per aorta from ApoE/FNfl/fl (n¼9) and
ApoE/FNVavCre (n¼ 9) mice. Values are per-
centage SD; p¼ 0.78. n.s.¼ not significant.
E. Quantification of the relative size of single
lesions. Values are mean SD; p¼ 0.27, 0.08,
0.41 and 0.055. n.s.¼ not significant.
568To further confirm these results, we cultured ECs in the presence
and absence of pFN and monitored the expression of ICAM-1 by
WB. In line with our in vivo results, ICAM-1 levels were reduced
in ECs when they were cultured in the absence of pFN (Fig 5B).
Adhesion of monocytes to the endothelium is required for
the initiation of atherosclerosis (Woollard & Geissmann, 2010).
To analyze whether pFN depositions modulate adhesion of
monocytes to ECs, we analyzed leukocyte adhesion on the
endothelium in atherosclerosis-prone regions of the carotid
artery of ApoE/FNfl/fl and ApoE/FNMxCre mice using
intravital microscopy and found that the number of adherent
leukocytes was reduced in ApoE/FNMxCre mice when
compared to ApoE/FNfl/fl control littermates (Fig 5C and
D). Since the number of circulating leukocytes is influencing
their adhesion to the endothelium, we determined their
numbers and found that they were similar in ApoE/FNfl/fl
and ApoE/FNMxCre mice (unpublished observation). The
adhesion of leukocytes to the endothelium is mediated by the
interaction of a4b1 integrins to VCAM-1 (Barringhaus et al,
2004). Immunostaining of cross-sections of aortic arches
with anti-VCAM-1 antibodies and FACS analyses of leukocytes 2012 EMBO Molecular Medicineto quantify a4b1 integrin surface levels revealed normal
levels of both adhesion molecules in ApoE/FNfl/fl and
ApoE/FNMxCre mice fed for 1 week with a high-fat diet
(Supporting Information Fig 2B and 2C).
Next, we measured cell adhesion of Mac-1-positive cells to
monolayers of ECs under static and laminar flow conditions,
both in the presence and absence of pFN. We used bEnd5
endothelioma cells to test adhesion, since they were shown to
promote adhesion of haematopoietic cells equally well as
primary ECs (Steiner et al, 2010). Mac-1-positive cells cultured
in absence of pFN were suspended in pFN-free medium or pFN-
complemented medium (10mg/ml) and then seeded onto a
bEnd5 monolayer. Quantification of adherent cells revealed that
twofold more Mac-1-positive cells adhered to the bEnd5
monolayer when they were cultured in pFN-complemented
medium as compared to pFN-free medium (Fig 5E), indicating
that soluble pFN promotes adhesion of Mac-1-positive cells
to ECs.
During atherosclerosis, low-density lipoprotein (LDL) parti-
cles aggregate and become oxidized in the vascular ECM.
Oxidized LDL will be taken up by macrophages resulting in theEMBO Mol Med 4, 564–576 www.embomolmed.org
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Figure 4. Reduced FN depositions in the aortic arch of ApoE/FNMxCre mice.
A. Immunostaining of FN in the lesser curvature of the aortic arch from ApoE/FNMxCre, ApoE/FNVavCre mice and their respective ApoE/FNfl/fl mice.
Arrowheads point to FN signals at the luminal side of the arch. Nuclei are visualized with DAPI. Scale bar represents 75mm in all images.
B. Fasting cholesterol and HDL cholesterol levels of ApoE/FNfl/fl (n¼ 13) and ApoE/FNMxCre (n¼ 13) mice after 12 weeks on a high-fat diet. Values are
mean SD; p¼0.33. n.s.¼not significant.
C. Fasting glucose levels of ApoE/FNfl/fl (n¼13) and ApoE/FNMxCre (n¼ 13) mice after 12 weeks on a high-fat diet. Values are mean SD; p¼0.15. n.s.¼not
significant.
D. Body weight of ApoE/FNfl/fl (n¼28) and ApoE/FNMxCre (n¼16) mice after 12 weeks on a high fat-diet. Values are mean SD; p¼0.11. n.s.¼not
significant.
www.embomolmed.org EMBO Mol Med 4, 564–576  2012 EMBO Molecular Medicine 569
Research Article
Plasma fibronectin in atherosclerosis
Figure 5. Reduced NF-kB and PAK activation and
macrophage recruitment into atheroprone areas
of ApoE/FNMxCre mice.
A. Immunostaining of phosho-NFkB/p65, phospho-
PAK, phospho-JNK and ICAM-1 in the lesser
curvature of the aortic arch from ApoE/FNfl/fl
and ApoE/FNMxCre mice. Arrowheads point to
immunosignals in ECs.
B. Western blot for ICAM-1 in lysates from ECs
cultured for 36 h in the presence or absence of
pFN.
C. Adhesion of leukocytes and inflammatory
monocytes/neutrophils to carotid arteries of
ApoE/FNfl/fl and ApoE/FNMxCre mice fed with
high-fat diet for 4.5 weeks. Values are mean SD.
D. Representative images of inflammatory mono-
cytes/neutrophils adhering (arrowheads) to the
luminal side of the external carotid artery in
ApoE/FNfl/fl and ApoE/FNMxCre mice.
E. Quantification of adhesion of Mac-1-positive
cells on amonolayer of ECs under static condition
and laminar shear (2.5 dyne/cm2). Values are
mean SD and normalized to adherent cells in
the presence of FN in the culture medium;
p¼ 0.025, 0.023 and 0.029.
570formation of aggregated and oxidized LDL foam cells (Woollard
& Geissmann, 2010). To test whether pFN modulates lipid
accumulation in plaques, we stained cross-sections of athero-
sclerotic plaques from ApoE/FNfl/fl and ApoE/FNMxCre
mice with Oil Red O. Lipids were detected in the core region of
the plaques and a similar lipid accumulation was found in
ApoE/FNfl/fl and ApoE/FNMxCre mice (Fig 6A).
To determine whether FN affects macrophage uptake of
modified LDL, we incubated freshly isolated macrophages from
ApoE/FNfl/fl and ApoE/FNMxCre mice (Supporting Informa-
tion Fig 3) with LDL and acLDL and then stained them with Oil
Red O. The intracellular lipid accumulation was similar in
macrophages from ApoE/FNfl/fl and ApoE/FNMxCre mice
(Fig 6B). Finally, we quantified the acLDL uptake by macro- 2012 EMBO Molecular Medicinephages from ApoE/FNfl/fl and ApoE/FNMxCre mice after
incubating them for 4 and 24 h with acLDL and found that also
the acLDL uptake was normal (Fig 6C). Collectively, these
results indicate that FN is dispensable for foam cell formation.
Atherosclerotic lesions in ApoE/FNMxCre mice lack the
fibrous cap
Advanced atherosclerotic lesions are characterized by a
subendothelial accumulation of vSMCs, which synthesize and
deposit a collagen- and FN-rich matrix into the fibrous cap
(Newby & Zaltsman, 1999). To test whether loss of pFN alters
fibrous cap formation, we immunostained cross-sections of
similarly sized atherosclerotic plaques from ApoE/FNfl/fl and
ApoE/FNMxCre mice for Mac-1 to visualize monocyte/EMBO Mol Med 4, 564–576 www.embomolmed.org
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Figure 6. Normal foam cell formation in
ApoE/FNMxCre mice.
A. Staining atherosclerotic plaques from
ApoE/FNfl/fl and ApoE/FNMxCre mice 12weeks
after a high fat diet with Oil Red O and haema-
toxylin. Scale bar represents 100mm.
B. Staining of macrophages from ApoE/FNfl/fl and
ApoE/FNMxCre mice with Oil Red O and
haematoxylin 24-h after incubating them with
LDL or AcLDL, respectively. Scale bar represents
20mm.
C. Quantification of acLDL uptake by macrophages
from ApoE/FNfl/fl and ApoE/FNMxCre mice.
Values are mean SD; p¼ 0.36 and 0.29.
n.s.¼ not significant.macrophages, Thy-1.2/CD3 to visualize T cells, alpha-smooth
muscle actin (aSMA) to visualize vSMCs and the ECM proteins
FN and collagen type I (Col-I). After 12 weeks of high-fat diet,
atherosclerotic plaques from ApoE/FNfl/fl mice consisted of
macrophage-derived foam cells that were covered at the luminal
side with a FN- and collagen-rich matrix and a continuous layer
of vSMCs (Fig 7A and B and Supporting Information Fig 4A). A
few T cells were detected, mainly at the edges of a few plaques
(Supporting Information Fig 4B). In sharp contrast, athero-
sclerotic plaques from ApoE/FNMxCre mice lacked vSMCs and
a collagen matrix and consisted mainly of macrophage-derived
foam cells (Fig 7 A and B and Supporting Information Fig 4A).
Similarly, atherosclerotic plaques of ApoE/FNMxCre mice fed
for 6 months with a high-fat diet also lacked vSMCs and a
collagen matrix. Distribution and number of T cells were
unaffected in ApoE/FNMxCre mice (Supporting Information
Fig 4B).
To determine whether monocyte/macrophage-derived FN
contributes to vSMCs recruitment and fibrous cap formation, wewww.embomolmed.org EMBO Mol Med 4, 564–576analyzed lesions from ApoE/FNVavCre mice and found that the
cellular composition of their lesions and the FN deposits in their
fibrous caps were similar to ApoE/FNfl/fl control littermates
(Supporting Information Fig 4C). Together, these results
indicate that pFN plays an important role in promoting the
formation of the fibrous cap.
pFN stimulates vSMC migration
Why do vSMCs fail to colonize the fibrous caps in
ApoE/FNMxCre mice? Successful accumulation of vSMCs in
atherosclerotic lesions and subsequent formation of the fibrous
cap depends on a number of factors including vSMC prolifera-
tion and survival rates as well as their ability to migrate into the
lesions (Newby & Zaltsman, 1999). We found no apparent
defects in vSMCs proliferation nor did we observe increased
apoptosis in lesions from ApoE/FNMxCre mice subjected to
high-fat diet. To test whether pFN modulates migration of
vSMCs, we isolated primary vSMCs and performed chemotaxis
assays using transwell motility chambers using pFN as a 2012 EMBO Molecular Medicine 571
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Figure 7. Atherosclerotic lesions from
ApoE/FNMxCre mice lack fibrous caps.
A. Immunostaining of atherosclerotic plaques from
ApoE/FNfl/fl and ApoE/FNMxCre mice after
12 weeks of high fat diet for FN, macrophage
antigen-1 (Mac-1) and aSMA. Arrowheads point
to aSMA immunosignals in the fibrous cap. Nuclei
are visualized with DAPI. Scale bar represents
75mm.
B. Immunostaining of atherosclerotic plaques from
ApoE/FNfl/fl and ApoE/FNMxCre mice after
12 weeks of high fat diet with antibodies against
collagen I and aSMA. White dotted line displays
plaque surface. aSMA stains the luminal side
(arrowheads). Nuclei are visualized with DAPI.
Scale bar represents 75mm.
C. Quantification of vSMC migration against FN in
the lower part of Transwell chambers. Control
medium lacking FN (0) was used to assess
baseline migration.
D. Quantification of vSMCmigration against plasma
from ApoE/FNfl/fl, ApoE/FNMxCre mice with
and without supplementation of FN (12mg/ml).
Values are percentage of migrating cells SD;
p¼ 0.0045 and 0.1. n.s.¼ not significant.
572chemoattractant in the lower part of the chambers. We observed
that pFN increased the migration of vSMCs in a concentration-
dependent manner (Fig 7C). When we added plasma samples
from ApoE/FNfl/fl and ApoE/FNMxCre mice to the lower
part of the migration chamber, we found that plasma from
ApoE/FNfl/fl mice induced twofold higher migration rates
of vSMCs than plasma from ApoE/FNMxCre mice (Fig 7D).
Importantly, the decreased migration rates of vSMCs towards
plasma derived from ApoE/FNMxCre mice could be rescued by
supplementing the plasma with FN (Fig 7D). These results
clearly indicate that pFN is a motility factor for vSMCs.DISCUSSION
FN deposits and atherosclerotic lesions preferentially form at
sites of disturbed blood flow (Hahn & Schwartz, 2009). In vitro
studies with shear-stressed ECs cultured on FN suggest that the
FN deposits enforce and maintain a pro-atherogenic milieu
through integrin binding and signalling (Feaver et al, 2010). It is
not known, however, whether FN serves a similar function 2012 EMBO Molecular Medicinein vivo and whether the FN depositions are derived from the
circulation or from infiltrating monocytes and/or resident ECs.
To address these questions, we generated mice lacking the FN
gene either in hepatocytes and/or haematopoietic cells and
crossed them with atherosclerosis-prone ApoE-null mice and
fed them a high-fat diet. Loss of FN expression in blood cells
modulated neither the development nor progression of athero-
sclerosis in mice. In contrast, loss of pFN abrogated FN
depositions at atherosclerosis-prone sites resulting in the
formation of smaller and fewer atherosclerotic lesions. How-
ever, theywere covered onlywith a thin layer ofmatrix proteins,
which is usually a sign of fragility and increased susceptibility
for ruptures in human atherosclerotic plaques. These findings
suggest a dual function for pFN during atherosclerosis: it
supports plaque initiation by providing an adhesive matrix for
monocytes and at late stages, it protects the lesions by
controlling the formation of the fibrous cap. Thus, targeting
atheroma initiation and growth by modulating FN production
might have the unforeseen consequences of promoting plaque
rupture and arterial occlusions resulting in a significant increase
in vascular morbidity and mortality.EMBO Mol Med 4, 564–576 www.embomolmed.org
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mainly composed of basement membrane (BM) components
including collagen IV and laminins. During pathological
situations such as inflammation, wound healing or athero-
sclerosis transitional matrix proteins such as FN or fibrinogen
are deposited into the subendothelial matrix (Hahn & Schwartz,
2009). In atherosclerosis, FN is deposited at sites of disturbed
flow before fatty streaks are formed (Hahn & Schwartz, 2009;
Hahn et al, 2009; Orr et al, 2005) but the source of the FN
deposits is not known. In vitro studies have shown that
disturbed flow induces the expression and deposition of FN by
ECs (Feaver et al, 2010) suggesting that shear-stressed ECs
deposit FN into the vessel wall. We confirmed these findings
showing that FN is indeed deposited into the subendothelial
space at sites of disturbed blood flow. Since pFN can be
transferred from the plasma into tissues (Moretti et al, 2007; Oh
et al, 1981), we next tested whether pFN contributes to the FN
depositions. To this end, we ablated a conditional FN-null allele
in ApoE-null mice with theMx-Cre transgene (ApoE/FNMxCre)
that deletes efficiently in hepatocytes and haematopoietic cells,
and fed the offspring a high fat diet. The Mx-Cre transgene can
also delete genes at low efficiency in other tissues than liver and
blood cells, which is, however, efficiently compensated by
diffusion of FN from non-deleted neighbouring cells (Sakai et al,
2001). The ApoE/FNMxCre offspring showed very little FN at
atheroprone areas suggesting that pFN represents a major
source for FN depositions at the atherosclerosis-prone areas of
the vasculature. The presence of residual FN in vessel walls
of ApoE/FNMxCre mice indicates that small contributions from
ECs and/or vSMCs may add to the FN depositions at
atherosclerosis-prone areas. Previous reports associating
increased pFN levels with atherosclerosis (Orem et al, 2003)
and ischemic heart disease (Ozcelik et al, 2009; Song et al, 2001;
Taznatos et al, 2009) support a role of pFN as atherosclerosis
promoting factor. On the other hand, however, it has also been
shown that pFN levels were unchanged or even decreased in
cohorts of atherosclerosis patients (Vavalle et al, 2007; Zhang et al,
2006). It is thus possible that other risk factors, which probably
depend on the patient population, are able to either attenuate or
aggravate the effect of pFN on the course of atherosclerosis.
Unfortunately, the nature of these risk factors is not known.
In atherosclerosis, it is believed that binding of fibrillar
collagens to a2b1 prevents pro-inflammatory signals, while FN
sustains a shear-stressed induced inflammatory environment
and therefore is thought to aggravate the course of the disease.
Mechanistically, FN mediates its pro-inflammatory role through
b1-containing integrins, most likely a5b1 (Orr et al, 2006),
which in turn induces phosphorylation of NF-kB through the
activation of the small GTPase Rac1 (Tzima et al, 2002). In
line with these findings we found that ECs of ApoE/FNMxCre
mice contain significantly less of the phosphorylated NF-kB
subunit p65 and less phosphorylated PAK, and develop smaller
plaques than control mice. In line with reduced NF-kB activity
we also observed reduced expression of the downstream
gene ICAM-1 on ECs. Consequently, the adhesion of monocytes
to the endothelium at atherosclerosis-prone regions in
ApoE/FNMxCre mice was also reduced when compared towww.embomolmed.org EMBO Mol Med 4, 564–576control littermates, providing a good explanation for the
reduced recruitment of monocytes to atherosclerosis-prone
sites. Interestingly, we found that the levels of inflammatory
markers in developed lesions of ApoE/FNMxCre mice were
comparable with those of control mice, indicating that pFN is
required for inflammation during plaque initiation, but not
anymore once the plaques have formed. Since the deletion of the
FN gene in monocytes by Vav-Cre did not affect the course of
atherosclerosis, we expected normal monocyte recruitment to
plaques in these mice, although we did not confirm this by
intravital microscopy. In summary, we collected several lines of
evidence suggesting that monocyte recruitment is indeed
impaired in pFN-deficient mice: the expression of ICAM-1 on
ECs was markedly reduced, the adhesion of monocytes to the
endothelium was reduced in pFN-deficient mice, and the
number and size of atherosclerotic plaques was significantly
diminished in ApoE/FNMxCre mice.
The reduced number and size of atherosclerotic plaques in
ApoE/FNMxCre mice corroborate previous observations made
using in vitro systems. In addition, our findings revealed a
previously unknown function for FN in atherosclerosis. Almost all
atherosclerotic lesions in ApoE/FNMxCre mice were devoid of
vSMC, contained reduced levels of collagen I and lacked a fibrous
cap, which points to a role for FN in the reinforcement of
atherosclerotic plaques. Atherosclerotic plaques that are not
stabilized with fibrous caps in humans lead to an increased
likelihood of rupture and subsequent thrombus-mediated vas-
cular occlusion leading to myocardial infarction, stroke and
sudden death (Lusis, 2000). Unfortunately, plaque ruptures with
thrombosis do not occur in mouse models and therefore, the
consequences could not be tested (Glass & Witztum, 2001;
Libby et al, 2011). The formation of a fibrous cap critically
depends on the activation and proliferation of vSMCs in the intima
of the affected vessel and their subsequent migration into the
plaque area where they deposit a collagen-rich matrix. Since we
found normal proliferation and survival rates of vSMCs in
ApoE/FNMxCre mice, we conclude that the vascular FN deposits
represent a trigger for the recruitment of vSMCs. This notion is
supported by our in vitro experiments demonstrating that vSMCs
were less efficient at migrating towards plasma lacking pFN.
These new findings strongly argue against the use of inhibitors
designed to treat atherosclerosis by blocking the function of FN,
such as by using peptides derived from FN. This type of treatment
would inhibit pro-inflammatory signalling and thus reduce the
number and size of atherosclerotic plaques but would also at the
same time destabilize these plaques and increase the danger of
thrombus formation and thrombotic diseases. Furthermore,
reducing pFN levels would also destabilize thrombi and trigger
the shedding of platelet clumps into the circulation (Ni et al, 2003)
resulting in chronic embolism.MATERIALS AND METHODS
Animal procedures
ApoE/ (Jackson Laboratory) and FNfl/fl mice (Sakai et al, 2001) were
intercrossed with Mx-Cre transgenic mice (Kuhn et al, 1995; Schneider 2012 EMBO Molecular Medicine 573
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The paper explained
PROBLEM:
Vascular occlusion of atheromatous arteries is the commonest
cause of death in the western world. The main cause of vascular
occlusions is the rupture of atherosclerotic plaques followed by
thrombus formation. Atherosclerotic plaques are asymmetric
focal thickenings of the artery consisting of lipids, various cell
types and ECM including FN. Expression of FN is elevated in
vessel walls of atherosclerotic regions, however, the source and
functions of FN in atherosclerosis are not clear.
RESULTS:
In our study, we show that atherosclerosis-prone mice lacking
hepatocyte-derived pFN and fed with a pro-atherogenic diet lack
FN deposits and show reduced pro-inflammatory signals at
atherosclerosis-prone areas resulting in significantly smaller and
fewer atherosclerotic plaques. Unexpectedly, the atherosclerotic
lesions were devoid of fibrous caps, which play an important role
for plaque stability and to prevent plaque rupture.
IMPACT:
Our results demonstrate that FN plays a dichotomous role in
atherosclerosis: while FN worsens the course of atherosclerosis
by increasing the atherogenic plaque area, it stabilizes the
plaques with fibrous caps and protects from secondary damage
and vascular occlusion.
574et al, 2003) to produce ApoE/FNMxCre mice, or with Vav-Cre
transgenic mice (Georgiades et al, 2002) to produce ApoE/FNVavCre
mice. Deletion of the floxed FN alleles was induced in 2-week-old mice
by a single intraperitoneal injection of 175mg poly-IC (Sigma).
Atherosclerosis was accelerated by feeding the mice for 12 weeks
with a high fat diet (provided by Altromin, Lage/Lippe, Germany)
containing 21% fat, 0.15% cholesterol but lacking cholate (composi-
tion according to Harlan Teklad TD88137 diet). All experiments with
mice were performed in accordance to German guidelines and
regulations.
Atherosclerotic lesion analysis
Mice were anesthetized with Avertin, hearts were perfused with 15ml
of phosphate-buffered saline (PBS) containing 5mM ethylenediami-
netetracetic acid (EDTA) and then with PBS containing 2% parafor-
maldehyde (PFA), 7.5% sucrose. The adventitia was thoroughly cleaned
under a dissecting microscope, and the aorta was cut open
longitudinally and pinned on to a silicone plate. After 5min
equilibration in 60% isopropanol, aortas were stained with Oil Red
O (Sigma, Germany), plaques were analyzed under the Leica MZ16FA
stereomicroscope, and quantified with Metamorph1 software. The
aortic lesions of each animal are presented as percentage of the total
aortic luminal surface area.
Plasma cholesterol
Total and HDL cholesterol levels in plasma were quantified as
previously described (Dunér et al, 2011; Fredrikson et al, 2003).
Plasma glucose measurement
Plasma glucose was measured using a commercial kit (Abcam).
Antibodies
The following antibodies were used: biotinylated rat anti-Mac-1
monoclonal antibody (Pharmingen), CD3-PE, Thy-1.2 CD90.2, GM-
130, ICAM-1, PECAM-1 (CD31) (all from Pharmingen), Cy3-coupled
mouse anti-aSMA antibody (Sigma), rabbit anti-FN polyclonal anti-
body (Millipore), rabbit anti-Col-I antibody (Millipore), phospho-NFkB 2012 EMBO Molecular Medicinep65 (Santa Cruz), phospho-PAK1/2 (Cell Signaling), phosphor-JNK (Cell
Signaling). Secondary antibodies were purchased from Jackson
Immuno Research Laboratories, Molecular Probes or Invitrogen.
Histology and immunostaining
Heart and aorta tissues were embedded into a cryo-matrix (Thermo)
and 10 or 12mm sections were prepared using a cryotome. Sections
were blocked with 3% bovine serum albumin (BSA) 0.2% Triton-X in
PBS and incubated with antibodies.
Intravital microscopy
Intravital microscopy of the left carotid artery was performed as
described previously (Drechsler et al, 2010). The left jugular vein was
cannulated with polyethylene tubing (PE50) for the intravenous
administration of anti-Gr1 antibodies (RB6-8C5, 2.5mg/mouse) for
visualizing inflammatory monocytes and neutrophils and rhodamine 6G
to visualize total leukocytes. Intravital microscopy was performed with
an Olympus BX51 microscope equipped with a Hamamatsu 9100-02
EMCCD camera and a 10 saline-immersion objective. For image
acquisition and analysis Olympus cellR software was used.
Isolation of smooth muscle cells
Aortas were dissected, longitudinally opened, washed with PBS, cut
and digested with digestion buffer (2mg/ml collagenase type II and
0.5mg/ml elastase in Dulbecco’s modified Eagle medium (DMEM)) for
30min at 378C. Digestion was terminated with 10% foetal bovine
serum (FBS) in DMEM. Released cells were centrifuged and re-
suspended in DMEM containing 10% FBS, transferred to 6-well dishes
and further expanded for analysis.
Isolation of aortic endothelial cells
Cells were isolated as previously described (Kobayashi et al, 2005).
In vitro foam cell formation assay
Thioglycolate-elicited peritoneal macrophages were plated on 12-well
plates in macrophage serum-free medium (Macrophage-SFM, Invitro-
gen). After 24 h, non-adherent cells were washed off, and macro-EMBO Mol Med 4, 564–576 www.embomolmed.org
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with 50mg/ml native, acetylated human LDL (acLDL) or buffer control
for 24–72h. Cells were stained for 60min with Oil Red O and
counterstained with haematoxylin.
Modified LDL uptake
Thioglycolate-elicited peritoneal macrophages were plated on cover-
slips in macrophage serum-free medium (Invitrogen). After 24 h, non-
adherent cells were washed off and adherent macrophages were
incubated in serum-free medium complemented with 10mg/ml
native, acLDL:Dil for 4 or 24 h. Afterwards cells were washed with
PBS, fixed with 4% PFA and nuclei were stained with 4,6-diamidino-2-
phenylindole (DAPI). Fluorescence was analyzed with ImageJ software.
Five microscopic fields were counted per experiment.
SDS–PAGE and immunoblotting
Plasma samples and cells were incubated in lysis buffer (150mM
NaCl, 50mM Tris pH 7.4, 1mM EDTA, 1% Triton X-100 supplemented
with protease inhibitors (Roche)), homogenized in Laemmli sample
buffer and boiled for 5min. Proteins were resolved by SDS–
polyacrylamide gel electrophoresis (SDS–PAGE) gels and then electro-
phoretically transferred from the gels onto nitrocellulose membranes,
which were subsequently incubation with antibodies. Bound anti-
bodies were detected using enhanced chemiluminescence (Millipore
Corporation, Billerica, USA).
Migration assay
Migration assays were performed in 8mm pore size chamber inserts
(BD Falcon). 4104 vSMCs were seeded into the chambers, which
were then transferred into 24-well plates containing serum-free
medium supplemented with dilutions of pFN or plasma from control
and ApoE/FNMxCre mice, respectively.
After an overnight incubation, the cells in the bottom part of the
chamber were fixed in 4% PFA and stained with 0.2% crystal violet.
Five microscopic fields per chamber were counted. Data are
represented as percentage of reference cell number/field. Three
independent experiments were performed, each of them in triplicate.
Adhesion assays
Adhesion assays of primary peritoneal macrophages to the endothe-
lioma cell line bEnd5 were carried out as follows. bEnd5 cells were
cultured in serum-free medium in 4-well NUNC chamber slides until
confluence, either on 1mg/ml FN or on plastic. Macrophages were
isolated and co-cultured with bEnd5 cells for 6 h, either with
additional FN (10mg/ml) or without in the medium. Cells were
washed with PBS, fixed with 4% PFA and stained for Mac-1. Six
microscopic fields were counted per experiment.
Adhesion assays of primary peritoneal macrophages under flow
conditions were carried out with bEnd5 cells. bEnd5 cells were
cultured in serum-free medium or serum-free medium containing
10mg/ml FN in a m-Slide I 0.4 Luer (Ibidi) over night. Primary
macrophages were isolated and cultured in FN-free medium or
medium containing 10mg/ml FN. Macrophages were perfused at
2.5 dyne/cm2 at 378C over the endothelial monolayer for 10min. Cells
were washed with PBS, fixed with 4% PFA, stained for the Mac-1
antigen and the adherent macrophages were then counted in 10
microscopic fields per experiment.www.embomolmed.org EMBO Mol Med 4, 564–576Statistical analysis
The statistical analysis was performed using the Student’s-t-test. The
values are presented as mean SD.Author contributions
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